{"result": "Here is a comprehensive summary of the data:\n\n\"Pivot X is a renowned author who has contributed to several significant studies in the field of breast cancer research. Specifically, Pivot X is an author of a randomized phase III trial on Adjuvant bevacizumab-containing therapy in triple-negative breast cancer, as well as a study on AVEREL, a randomized phase III trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer. Additionally, Pivot X has also authored a study on adjuvant bevacizumab-containing therapy in triple-negative breast cancer. These studies demonstrate Pivot X's expertise and commitment to advancing our understanding of breast cancer treatment options.\"", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"PIVOT X\\\"\"\nDescription List: [\"\\\"Pivot X is an author of a study on Adjuvant bevacizumab-containing therapy in triple-negative breast cancer: a randomized phase III trial.\\\"\\\"Pivot X is an author of a study on AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.\\\"\", \"\\\"Pivot X is an author of a study on adjuvant bevacizumab-containing therapy in triple-negative breast cancer.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}